Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,521 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
S-8 File 333-198732

REGISTRATION STATEMENT

Filing date
15 Sep 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
09 Sep 2014
Reporting date
05 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Sep 2014
Reporting date
08 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
08 Sep 2014
Reporting date
08 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
22 Aug 2014
Reporting date
21 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Aug 2014
Reporting date
10 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-11460

QUARTERLY REPORT

Filing date
14 Aug 2014
Reporting date
30 Jun 2014
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
13 Aug 2014
Reporting date
13 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT

Filing date
10 Jun 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-11460

NTN BUZZTIME, INC.

Filing date
15 May 2014
Reporting date
31 Mar 2014
Next action
Verify source filing
4

FORM 4

Filing date
14 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
14 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
14 May 2014
Reporting date
14 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 May 2014
Reporting date
05 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-11460

NTN BUZZTIME

Filing date
25 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-11460

DEF 14A

Filing date
25 Apr 2014
Reporting date
06 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42217

AMENDMENT NO. 7

Filing date
21 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

FORM 8-K

Filing date
17 Apr 2014
Reporting date
17 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME

Filing date
16 Apr 2014
Reporting date
16 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-193012

FINAL PROSPECTUS

Filing date
11 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT

Filing date
11 Apr 2014
Reporting date
11 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .